Experimental Medicine and Biomedicine

Our aim is to pioneer innovative approaches for disease prevention and treatment by bringing together researchers who are world-leaders in experimentation and innovation.

The work we do spans the entire spectrum of experimental research; from early discovery in fundamental molecular and cellular studies, through to pre-clinical and clinical investigations, transforming lives through clinical trials and implementing changes in practice. Through our close engagement with local and global communities, collaborators, and funders we are helping to bring positive changes to people’s lives - from socio-economically deprived communities in the UK to aiding impoverished regions internationally.

Our researchers benefit from these state-of-the-art resources and infrastructure at the University of York including specialised laboratories in the Bioscience Technology Facility, enabling us to push the boundaries of scientific discovery. Our research also forms a crucial part of the York Biomedical Research Institute.

Clinical research at York is a joint venture, combining the expertise and resource of Hull York Medical School, the University of York, York and Scarborough Teaching Hospitals NHS Foundation Trust (YSTHFT) and Hull University Teaching Hospitals NHS Trust.

Our research covers a number of areas in infectious diseases, HIV and immunology, as well as oncology, ophthalmology and rheumatology.

We deliver early phase trials (phase I and phase II) and support translational scientific research within York. We also design and support clinical studies in Asia, Africa, and South America.

Clinical Trials of Investigational Medicinal Products (CTIMP) trials delivered by York academics at York Hospital are jointly sponsored by the University of York and YSTHFT. There is also a clinical suite within the Department of Biology, University of York, where University-sponsored non-CTIMP studies can be conducted.

We also have access to the University of York’s Tissue Bank. This initiative aims to develop networks with the clinical care teams and provide researchers from both the hospital and University with access to human tissue for basic and translational research.